About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT01366027

PRISM Registry: Pseudobulbar Affect Registry Series

PBA is a neurologic condition that is estimated to impact over a million patients and their families in the United States. PBA occurs secondary to an otherwise unrelated neurologic disease or injury, ...

Lead sponsor: Avanir Pharmaceuticals•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Avanir Pharmaceuticals

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•All participants must have underlying neurologic conditions known to be risk factors of PBA: Alzheimer's Disease, Amyotrophic Lateral Sclerosis, Multiple Sclerosis, Parkinson's Disease, Stroke, and Traumatic Brain Injury.
•The population for this study will be 18 years and over

Related studies

RECRUITINGPhase 2

A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

NCT07033494 · Early Alzheimer's Disease

RECRUITINGPhase 2/3

ACP-204 in Adults With Alzheimer's Disease Psychosis

NCT06159673 · Alzheimer's Disease Psychosis

Lombard Cohort of Brain Health Services

NCT07457138 · Subjective Cognitive Decline (SCD), Functional Cognitive Disorder, and more

RECRUITINGPhase 4

Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis

NCT07225361 · Multiple Sclerosis, Multiple Sclerosis (MS) - Relapsing-remitting

RECRUITINGPhase 1/2

Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy

NCT05359653 · Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 16, 2014Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment5,290

Start dateMay 2011

Last updatedApr 16, 2014

Condition

Alzheimer's Disease Amyotrophic Lateral Sclerosis (ALS)Multiple Sclerosis (MS)Parkinson's Disease Stroke+1 more

Locations shown

Avanir Pharmaceuticals

Aliso Viejo, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 16, 2014Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions